| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.4 | 0.2 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.4 | 0.03 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.27 | 0.4 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.22 | 0.4 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.2 | 0.007 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |